Acadia Healthcare Company, Inc. (ACHC) News
Follow Acadia Healthcare Company, Inc. (ACHC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 25 public stories across 14 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Acadia Healthcare Raises FY2026 Financial Guidance
Acadia raised its full-year 2026 revenue, earnings and cash flow guidance and lowered its capital expenditure guidance after third-quarter revenue and Adjusted EBITDA growth.
EARNINGS | Nov 05, 2026, 02:33 PM UTC
M
Acadia Healthcare Reports Q3 Revenue of $895.3 Million
Q3 revenue was $895.3 million, versus a FactSet estimate of $877.8 million.
EQUITY | Nov 04, 2026, 09:13 PM UTC
M
Acadia Healthcare Posts Q3 Adjusted EPS of $0.60 per Share
Q3 adjusted EPS was $0.60 per share, versus a FactSet estimate of $0.46.
EARNINGS | Nov 04, 2026, 09:12 PM UTC
M
Acadia Healthcare Reports Third-Quarter Results, Raises 2026 Guidance
Acadia Healthcare announced results for the quarter ended September 30, 2026, and raised its full-year 2026 financial guidance.
EQUITY | Nov 04, 2026, 09:07 PM UTC
L
Acadia Healthcare preliminarily approved $12M insurer-funded settlement, $4.75M fees
Acadia Healthcare secured preliminary court approval of a settlement providing a $12,000,000 insurer-paid cash payment and corporate governance reforms.Key Highlights:Original SEC Filing: Acadia Healthcare Company, Inc.
REGULATION | Sep 25, 2026, 08:24 PM UTC
L
Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement
Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement
NEWS | Sep 25, 2026, 08:05 PM UTC
L
Acadia Healthcare Is Maintained at Market Perform by Leerink Partners
Ratings actions from Benzinga: GMT) Acadia Healthcare Price Target Raised to $33.00/Share From $30.00 by Leerink PartnersRatings actions from Benzinga
NEWS | Sep 23, 2026, 01:24 PM UTC
L
Leerink Partners maintains Market Perform rating on Acadia Healthcare Co, $33 price target
Leerink Partners maintained their Market Perform rating on Acadia Healthcare Co's stock with a price target of $33.00.The price target implies an upside of 12.4% from the Sep 22 close of $29.37.Key takeaways from the ana
EQUITY | Sep 23, 2026, 01:13 PM UTC
L
ACHC: Management targets $200M EBITDA growth, driven by strong demand and operational execution
Strong demand and stable revenue trends are driving growth, with management confident in achieving $200 million incremental EBITDA from new beds and operational improvements. Facility ramp-up, disciplined cost management
NEWS | Sep 14, 2026, 08:44 PM UTC
L
ACHC: Record bed growth, strong demand, and disciplined execution position the company for $200M EBITDA upside
Strong demand and disciplined cost management are driving revenue growth and operational improvements, with management confident in achieving $200 million incremental EBITDA from new beds. Labor and payer environments re
NEWS | Sep 14, 2026, 08:19 PM UTC
L
ACHC - Acadia Healthcare to Participate in 2026 Jefferies Healthcare Services and Technology Conference
ACHC - Acadia Healthcare to Participate in 2026 Jefferies Healthcare Services and Technology Conference
EQUITY | Sep 09, 2026, 01:05 PM UTC
L
Acadia Healthcare to participate in 2026 Jefferies conference webcast
Acadia Healthcare (ACHC) said it will take part in a fireside chat at the 2026 Jefferies Healthcare Services and Technology Conference, with an online webcast tied to the event.
EQUITY | Sep 09, 2026, 01:00 PM UTC
L
ACHC - Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
ACHC - Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
EQUITY | Aug 25, 2026, 02:18 PM UTC
L
ACHC - Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
ACHC - Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
EQUITY | Aug 12, 2026, 07:27 PM UTC
H
Acadia Healthcare lawsuit survives
Lawsuit against Acadia Healthcare moves forward
FX | Jul 31, 2026, 02:01 PM UTC
L
ACHC earnings recap - Solid Core Performance, but Some Noise @ KEYB
ACHC earnings recap - Solid Core Performance, but Some Noise @ KEYB
EARNINGS | Jul 30, 2026, 10:46 AM UTC
H
ACHC PT Raised to $14.50 at BAML
ACHC price target raised to $14.50
EQUITY | Jul 29, 2026, 12:34 PM UTC
L
ACHC Q2 adj. EPS $0.38 vs. est. $0.35, beat by $0.03; revenue $865.8Mm vs. est. $844.2Mm, above expectations on inpatient growth but pressur
ACHC Q2 adj. EPS $0.38 vs. est. $0.35, beat by $0.03; revenue $865.8Mm vs. est. $844.2Mm, above expectations on inpatient growth but pressured by higher costs; Q2 adj. EBITDA $149.2Mm vs. est. $148.2Mm; FY26 guidance upd
EARNINGS | Jul 28, 2026, 08:35 PM UTC
L
Acadia Healthcare narrows FY26 adjusted EPS view $1.45-$1.60 from $1.35-$1.60
Consensus $1.52. Narrows...
EARNINGS | Jul 28, 2026, 08:14 PM UTC
L
Acadia Healthcare reports Q2 adjusted EPS 38c, consensus 35c
Reports Q2 revenue...
EARNINGS | Jul 28, 2026, 08:13 PM UTC
L
ACHC Acadia Healthcare RESULTS: Q2, Q2 Net Income $12.26M, Q2 REV $865.839M vs. EST $844.2M, Q2 ADJ EBITDA $149.2M vs. EST $148.2M, Acadia H
ACHC Acadia Healthcare RESULTS: Q2, Q2 Net Income $12.26M, Q2 REV $865.839M vs. EST $844.2M, Q2 ADJ EBITDA $149.2M vs. EST $148.2M, Acadia Healthcare Earnings Notes:, Outlook FY CAPEX $235-255M, Outlook FY ADJ EBITDA $59
EARNINGS | Jul 28, 2026, 08:08 PM UTC
L
Acadia Healthcare Co Raises FY2026 Adj EPS Guidance from $1.35-$1.60 to $2.55-$2.85 vs $1.51 Est; Raises FY2026 Sales Guidance from $3.370B
Acadia Healthcare Co (NASDAQ: ACHC ) raises FY2026 Adj EPS guidance from $1.35-$1.60 to $2.55-$2.85 vs $1.51 analyst estimate. Raises FY2026 sales outlook from $3.370 billion-$3.450 billion to $3.900 billion-$4.200 billi
EARNINGS | Jul 28, 2026, 08:07 PM UTC
H
earnings calendar: • earnings before the open: ab abg alks amt awi axta ba cac carr cbu CMS cnc cts curb cvlt dino dte ecl fele fmx glw GSK
earnings calendar: • earnings before the open: ab abg alks amt awi axta ba cac carr cbu CMS cnc cts curb cvlt dino dte ecl fele fmx glw GSK hlt hri hubb iny inio iqv itri itw ivz jblu ko naut osk pcar phg pii pny pypl rc
EQUITY | Jul 28, 2026, 10:47 AM UTC
L
Largest premium to VWAP LCID (+5.97%) COTY (+3.69%) XYZ (+2.65%) UAA (+2.41%) CNC (+2.36%) DKNG (+2.22%) ACHC (+2.2%) RH (+2.15%) CLX (+2.15
Largest premium to VWAP LCID (+5.97%) COTY (+3.69%) XYZ (+2.65%) UAA (+2.41%) CNC (+2.36%) DKNG (+2.22%) ACHC (+2.2%) RH (+2.15%) CLX (+2.15%) UA (+2.15%) (Russell 1000 names)
EQUITY | Jul 15, 2026, 03:26 PM UTC
L
UNH Raise PT to $475 from $400, ACHC to $40 from $30, BTSG to $80 from $60 and lower HCA to $475 from $510 in Healthcare services Q2 preview
UNH Raise PT to $475 from $400, ACHC to $40 from $30, BTSG to $80 from $60 and lower HCA to $475 from $510 in Healthcare services Q2 preview @ KEYB
EQUITY | Jul 14, 2026, 11:40 AM UTC